Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 5—May 2005
Letter

Barriers to Creutzfeldt-Jakob Disease Autopsies, California

On This Page
Article Metrics
1
citations of this article
EID Journal Metrics on Scopus

Cite This Article

To the Editor: The recent article by Louie et al. underscores a more general disparity between the need for autopsies in potential infectious disease deaths and our present national capacity (1). In addition to confirming Creutzfeldt-Jakob disease (CJD) and allowing the differentiation of classic and variant CJD, autopsies identify previously undetected infections, discover causative organisms in unexplained infectious disease deaths, and provide insights into the pathogenesis of new or unusual infections (2,3). This information is essential for public health and medical interventions.

As outlined by Louie et al., hospital autopsy rates have dropped to single digits, and concerns by pathologists about occupational risks and biosafety have likely contributed to this decline. Currently, the last stronghold of autopsy expertise is forensic pathology (4). However, the medicolegal death investigative system does not have jurisdiction over all potential infectious disease deaths nor is it adequately supported to assume the cases that are missed by our present hospital autopsy system. Additionally, many medicolegal and hospital autopsy facilities with outdated or poorly-designed air flow systems are ill suited to handle autopsies when infectious disease is suspected (5). Air-handling systems can be expensive to fix.

Reference centers such as the National Prion Disease Pathology Surveillance Center, while providing diagnostic expertise, fail to surmount the biosafety obstacles (real and perceived) that prevent pathologists from enthusiastically performing autopsies on those who died of potential infectious diseases, including prion diseases. One potential solution is the creation of regional centers of excellence for infectious disease autopsies that could operate in conjunction with a mobile containment autopsy facility (5,6). Such centers could provide diagnostic expertise as well as biosafety capacity.

Top

Kurt B. Nolte*Comments to Author 

Author affiliation: *University of New Mexico, Albuquerque, New Mexico, USA

Top

References

  1. Louie  JK, Gavali  SS, Belay  ED, Trevejo  R, Hammond  LH, Schonberger  LB, Barriers to Creutzfeldt-Jakob disease autopsies, California. Emerg Infect Dis. 2004;10:167780.PubMed
  2. Nolte  KB, Simpson  GL, Parrish  RG. Emerging infectious agents and the forensic pathologist: the New Mexico model. Arch Pathol Lab Med. 1996;120:1258.PubMed
  3. Schwartz  DA, Bryan  RT, Hughes  JM. Pathology and emerging infections—quo vadimus? Am J Pathol. 1995;147:152533.PubMed
  4. Hirsch  CS. Forensic pathology and the autopsy. Arch Pathol Lab Med. 1984;108:4849.PubMed
  5. Nolte  KB, Taylor  DG, Richmond  JY. Biosafety considerations for autopsy. Am J Forensic Med Pathol. 2002;23:10722. DOIPubMed
  6. Centers for Disease Control and Prevention. Medical examiners, coroners, and biologic terrorism: a guidebook for surveillance and case management. MMWR Recomm Rep. 2004;53(No. RR-8):127.PubMed

Top

Cite This Article

DOI: 10.3201/eid1105.041133

Related Links

Top

Table of Contents – Volume 11, Number 5—May 2005

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Kurt B. Nolte, Office of the Medical Investigator, MSC11 6030, University of New Mexico, Albuquerque, NM 87131-0001, USA; fax: 505-272-0727

Send To

character(s) remaining.

Comment submitted successfully, thank you for your feedback.

Top

Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external